ClinicalTrials.gg
Not yet recruitingNCT07873593Updated Oct 14, 2026

The Effects of Protocolized Breathing Exercises on Pulmonary Function in Adolescents With Cerebral Palsy.

An interventional study of Protocolized breathing exercises and Sham Breathing Exercises in Cerebral Palsy, sponsored by Semmelweis University. Not yet recruiting at 1 site in Hungary. Open to participants aged 12 Years to 22 Years. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Semmelweis University · Not applicable, Interventional, and Treatment

Updated Oct 14, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
360
Allocation
Randomized
Ages
12 Years to 22 Years
Sex
All
01

Study summary

This multicenter randomized controlled pilot trial evaluates whether an 8-week protocolized breathing exercise program improves pulmonary function and quality of life in adolescents and young adults with cerebral palsy. Participants are randomized to either a structured breathing exercise program added to usual pedagogical rehabilitation care or sham breathing exercises plus usual care.

The study assesses changes in spirometric outcomes (FVC, FEV₁, PEF) and patient-reported quality of life and emotional well-being. Participants complete respiratory assessments and questionnaires at baseline, post-intervention, and follow-up.

Read the detailed description

This multicenter randomized controlled pilot trial investigates the effects of a structured, protocolized breathing exercise program on pulmonary function and quality of life in adolescents and young adults with cerebral palsy (CP).

The study builds on evidence that individuals with CP are at increased risk of respiratory impairment due to motor dysfunction, reduced mobility, postural limitations, and oropharyngeal dysphagia, all of which may contribute to restrictive lung disease and long-term respiratory complications. In addition, individuals with CP frequently experience reduced quality of life and increased levels of emotional distress, including anxiety, depression, and stress.

The intervention is based on breathing exercises derived from the Conductive Education System (CES), a pedagogical rehabilitation care that integrates motor, cognitive, and functional training for individuals with CP. Although breathing exercises are commonly included in pedagogical rehabilitation practice, their clinical effectiveness has not previously been systematically evaluated.

Participants are adolescents and young adults aged approximately 12-22 years with a diagnosis of cerebral palsy, representing a wide range of motor severity (Gross Motor Function Classification System levels I-V). The study will conducted across multiple conductive education centers to increase generalizability and to reflect real-world rehabilitation settings.

Participants will randomized at the class or group level to either an intervention group or a control group. The intervention group receives an 8-week structured breathing exercise program in addition to standard care. The program consists of short, guided daily sessions (approximately 15 minutes per day), including deep breathing, abdominal breathing, controlled inhalation and exhalation patterns, and forced expiration exercises using simple aids (e.g., balloons or windmills). The control group receives usual care and performs sham breathing activities for only 3 minutes/day. During the sham condition, participants are instructed only to breathe naturally without performing any structured or guided breathing exercises. This approach is intended to control for attention and environmental exposure without providing active respiratory training.

Primary outcomes include pulmonary function measures assessed by spirometry, specifically forced vital capacity (FVC), forced expiratory volume in 1 second (FEV₁), and peak expiratory flow (PEF). Secondary outcomes include quality of life, emotional distress (depression, anxiety, and stress), eating and drinking ability, and drooling severity, all assessed using standardized validated questionnaires and classification tools.

Assessments are performed at baseline, immediately after the 8-week intervention, and at follow-up approximately 18 weeks after baseline. The study also explores whether motor function level (GMFCS) influences responsiveness to the intervention.

The main aim of this pilot trial is to evaluate the feasibility and generate preliminary evidence regarding the potential benefits of structured breathing exercises in this population.

02

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • quality of life
  • cerebral palsy
  • pulmonary function
03

In context

Cerebral Palsy

1,891 studies on the registry are indexed under Cerebral Palsy; 439 are open to participants now.

This study's planned enrollment of 360 is above the median of 34 across 1,396 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Semmelweis University is the lead sponsor of 139 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 22 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children and young adults with a diagnosis of CP
  2. GMFCS Levels I to V
  3. Ages ≥12 to ≤22 years
  4. Ability to perform spirometry
  5. Ability to follow instructions
  6. Informed consent signed by legal guardian

Exclusion criteria

Exclusion Criteria

  1. Use of respiratory support in the past 12 months
  2. Botulinum toxin injections within 12 months prior to enrolment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
360 participants (estimated)

Study arms

  • Experimental
    Intervention Arm

    In this group, participants receive pedagogical rehabilitation as standard rehabilitation care plus the procolized breathing exercesis. In this group, participants follow a strict protocol for breathing exercises over an 8-week period, performing them three times a day, Monday through Friday, for five minutes each session. They also adhered to prescribed ventilation guidelines, in addition to receiving standard rehabilitation care. During the intervention, participants perform respiratory exercises, including deep breathing, abdominal breathing, exhalation with vocalization, and forced exhalation. Each exercise is repeated five times, three times per day: twice in the morning and once in the afternoon. The exercises are conducted in a seated, corrected position, guided by rehabilitation specialists or special needs teachers who provide instructions and demonstrations. Teachers are provided with the exact protocol for the breathing exercises series.

    Behavioral: Protocolized breathing exercises

  • Sham comparator
    Control

    In this group, participants receive pedagogical rehabilitation as standard rehabilitation care plus sham breathing exercises. Participants in this group followed a strict 8-week protocol for breathing exercises, which included a sham breathing protocol, performing the exercises three times a day, Monday through Friday, for one minutes each session.During the sham condition, participants are instructed only to breathe naturally without performing any structured or guided breathing exercises. T

    Behavioral: Sham Breathing Exercises

Interventions

  • BehavioralProtocolized breathing exercises

    The investigator developed a protocolized breathing program based on a systematic review of Dr. András Pető's work. Exercises were designed to be simple and easily guided by video or a trained therapist. The intervention group receives an 8-week structured breathing exercise program in addition to standard care. The program consists of short, guided daily sessions (approximately 15 minutes per day), including deep breathing, abdominal breathing, controlled inhalation and exhalation patterns, and forced expiration exercises using simple aids (e.g., balloons or windmills). Therapists guided participants through a standardized rhythm (3-4 s inhalation, 1-2 s hold, 5-6 s exhalation), using playful tools such as windmills or balloons for forced exhalation.

  • BehavioralSham Breathing Exercises

    The control group receives usual care and performs sham breathing activities for only 3 minutes/day. During the sham condition, participants are instructed only to breathe naturally without performing any structured or guided breathing exercises. This approach is intended to control for attention and environmental exposure without providing active respiratory training.

06

What researchers measure

Primary outcomes

  1. Peak Expiratory Flow (PEF), Percentage of Predicted Value

    The primary outcome will asses the change in PEF measured by spirometry and will be performed by trained staff in accordance with the 2019 ATS/ERS Standardization of Spirometry Statement , using a validated Piston PDD 301/sh spirometer with standard accessories. Pulmonary parameters will be assessed in an upright sitting position using a spirometer with a nose clip, ensuring a tight lip seal around the mouthpiece. Higher values indicate greater peak expiratory flow.

    Time frame: Measurements at baseline (week 0) , week 8.

Secondary outcomes

  1. Peak Expiratory Flow (PEF), Percentage of Predicted Value

    Description: The primary outcome will asses the change in PEF measured by spirometry and will be performed by trained staff in accordance with the 2019 ATS/ERS Standardization of Spirometry Statement , using a validated Piston PDD 301/sh spirometer with standard accessories. PEF will be assessed in an upright sitting position using a spirometer with a nose clip, ensuring a tight lip seal around the mouthpiece. Higher values indicate greater peak expiratory flow.

    Time frame: Measurements at week 18

  2. Peak Expiratory Flow (PEF), Liters per Second

    Peak expiratory flow (PEF) will be measured by spirometry and reported in liters per second (L/s). Higher values indicate greater peak expiratory flow.

    Time frame: Measurements at baseline (week 0) , week 8, week 18

  3. Forced Vital Capacity (FVC), Percentage of Predicted Value

    Forced vital capacity (FVC) will be measured by spirometry and expressed as a percentage of the predicted value. Higher values indicate greater forced vital capacity relative to the predicted value.

    Time frame: Measurements at baseline (week 0) , week 8, week 18

  4. Forced Vital Capacity (FVC), Liters

    Forced vital capacity (FVC) will be measured by spirometry with participants in an upright sitting position. FVC will be reported in liters (L). Higher values indicate greater forced vital capacity.

    Time frame: Baseline (week 0), week 8, and week 18

  5. Forced Expiratory Volume in One Second (FEV1), Percentage of Predicted Value

    Forced expiratory volume in one second (FEV1) will be measured by spirometry and expressed as a percentage of the predicted value. Higher values indicate greater forced expiratory volume in one second relative to the predicted value.

    Time frame: Baseline (week 0), week 8, and week 18

  6. Forced Expiratory Volume in One Second (FEV1), Liters

    Forced expiratory volume in one second (FEV1) will be measured by spirometry with participants in an upright sitting position. FEV1 will be reported in liters (L). Higher values indicate greater forced expiratory volume in one second.

    Time frame: Baseline (week 0), week 8, and week 18

  7. Quality of Life: Cerebral Palsy Quality of Life Questionnaire for Adolescents (CP QOL-Teen)

    The Cerebral Palsy Quality of Life Questionnaire for Adolescents (CP QOL-Teen) self-report will be used to assess health-related quality of life. The questionnaire assesses the following domains: general well-being and participation, communication, functioning, family and friends, school, social and emotional well-being, acceptance, and pain.The domains are scored on a 0-100 scale, with higher scores indicating better quality of life.

    Time frame: Baseline (week 0), week 8, and week 18

  8. Psychological Distress

    Psychological distress will be assessed using the Depression Anxiety Stress Scales - 42 Items (DASS-42). The DASS-42 comprises three subscales assessing depression, anxiety, and stress. The total score is calculated by summing the scores of all 42 items and ranges from 0 to 126. Higher scores indicate greater psychological distress.

    Time frame: Baseline (week 0), week 8, and week 18

  9. Eating and drinking abilities

    The Eating and Drinking Ability Classification System (EDACS) classifies eating and drinking ability in people with cerebral palsy according to the safety and efficiency of oral intake. The classification ranges from Level I to Level V. Level I indicates that the person eats and drinks safely and efficiently, whereas Level V indicates that the person is unable to eat or drink safely. Higher levels indicate greater limitations in eating and drinking ability.

    Time frame: Measurements at baseline (week 0) , week 8, week 18

  10. Severity and Frequency of Drooling

    Drooling severity and frequency will be assessed using the Drooling Severity and Frequency Scale (DSFS), a standardized measure used to evaluate the extent and occurrence of drooling. Higher scores indicate greater drooling severity and frequency.

    Time frame: Measurements at baseline (week 0) , week 8, week 18

07

Study locations

1 site
  • Semmelweis University András Pető Faculty
    Budapest, Pest County 1125, Hungary
08

References and documents

Individual participant data

Plan to share: No — De-identified individual participant data underlying the results reported in this study will be available upon reasonable request to the corresponding investigator.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2027; primary completion for Sep 2027, 5 months later.

Of 882 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 5 months is below that.

Counting every sponsor, half of 900 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2026
First posted
Oct 14, 2026
StartEst.
Apr 5, 2027
Primary completionEst.
Sep 6, 2027
CompletionEst.
Sep 6, 2027
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07873593
Responsible party
Sponsor
First posted
Oct 14, 2026
Start date
Apr 5, 2027 (estimated)
Primary completion
Sep 6, 2027 (estimated)
Completion
Sep 6, 2027 (estimated)
Last update
Oct 14, 2026

Study contacts

Ibolya Túri, PhD.
Contact
túri.ibolya@semmelweis.hu
+3612241500 ext. 1553
Erika Kolumban, MA
Contact
kolumban.erika@semmelweis.hu
+3612241553
Ibolya Túri, PhD
principal investigator · Semmelweis Egyetem

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion